Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carles Gaig

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Neurology|April 7, 2017
Clinical manifestations of the anti-IgLON5 diseaseCarles Gaig, Francesc Graus, Yarko Compta, et al.
Acta Neuropathologica|August 30, 2023
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 diseaseEvelyn Berger-Sieczkowski, Verena Endmayr, Carmen Haider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 3, 2026
Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's diseaseNeus Falgàs, Núria Tort-Colet, Isabel Martín-Sobrino, et al.
Brain : a Journal of Neurology|April 15, 2021
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorderAmbra Stefani, Alex Iranzo, Evi Holzknecht, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
Nature and Science of Sleep|June 7, 2022
Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy DiagnosisZhongxing Zhang, Yves Dauvilliers, Giuseppe Plazzi, et al.
Brain : a Journal of Neurology|January 16, 2026
Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progressionRaphael Reinecke, Sophie Nitsch, Francisca Faber, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Frontiers in Immunology|June 3, 2024
HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 diseaseInga Koneczny, Stefan Macher, Markus Hutterer, et al.
Acta Neuropathologica|July 22, 2019
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagyChristopher P Cali, Maribel Patino, Yee Kit Tai, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Neurology|April 7, 2017
Clinical manifestations of the anti-IgLON5 diseaseCarles Gaig, Francesc Graus, Yarko Compta, et al.
Acta Neuropathologica|August 30, 2023
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 diseaseEvelyn Berger-Sieczkowski, Verena Endmayr, Carmen Haider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 3, 2026
Relationship between locus coeruleus and slow-wave sleep in aging and Alzheimer's diseaseNeus Falgàs, Núria Tort-Colet, Isabel Martín-Sobrino, et al.
Brain : a Journal of Neurology|April 15, 2021
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorderAmbra Stefani, Alex Iranzo, Evi Holzknecht, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
Nature and Science of Sleep|June 7, 2022
Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy DiagnosisZhongxing Zhang, Yves Dauvilliers, Giuseppe Plazzi, et al.
Brain : a Journal of Neurology|January 16, 2026
Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progressionRaphael Reinecke, Sophie Nitsch, Francisca Faber, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Frontiers in Immunology|June 3, 2024
HLA dependency and possible clinical relevance of intrathecally synthesized anti-IgLON5 IgG4 in anti-IgLON5 diseaseInga Koneczny, Stefan Macher, Markus Hutterer, et al.
Acta Neuropathologica|July 22, 2019
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagyChristopher P Cali, Maribel Patino, Yee Kit Tai, et al.
Pageof 17